DEERFIELD PARTNERS, L.P.'s Net Worth
$92.8 Million
Who is DEERFIELD PARTNERS, L.P.?
DEERFIELD PARTNERS, L.P. has an estimated net worth of $92.8 Million. This is based on reported shares across multiple companies, which include DYNAVAX TECHNOLOGIES CORP, ARENA PHARMACEUTICALS INC, Auspex Pharmaceuticals, Inc., REGENXBIO Inc., Oncology Institute, Inc., Nkarta, Inc., Revolution Medicines, Inc., DA32 Life Science Tech Acquisition Corp., RIGEL PHARMACEUTICALS INC, eHealth, Inc., Singular Genomics Systems, Inc., Deerfield Healthcare Technology Acquisitions Corp., Aclaris Therapeutics, Inc., Vanda Pharmaceuticals Inc., Generation Bio Co., ANTARES PHARMA, INC., AERIE PHARMACEUTICALS INC, Loxo Oncology, Inc., GRAYBUG VISION, INC., Acutus Medical, Inc., Xilio Therapeutics, Inc., Larimar Therapeutics, Inc., Terns Pharmaceuticals, Inc., Recro Pharma, Inc., CATALYST BIOSCIENCES, INC., Mallinckrodt plc, PROTEON THERAPEUTICS INC, AveXis, Inc., Annexon, Inc., Black Diamond Therapeutics, Inc., Ignyte Acquisition Corp., Werewolf Therapeutics, Inc., Oncorus, Inc., AUXILIUM PHARMACEUTICALS INC, NxStage Medical, Inc., PepGen Inc., HI TECH PHARMACAL CO INC, Kiniksa Pharmaceuticals, Ltd., PAR PHARMACEUTICAL COMPANIES, INC., Frazier Lifesciences Acquisition Corp, Nuvalent, Inc., ANADYS PHARMACEUTICALS INC, XENOPORT INC, ISTA PHARMACEUTICALS INC, SALIX PHARMACEUTICALS LTD, MEDICINES CO /DE, THIRD WAVE TECHNOLOGIES INC /WI, INSPIRE PHARMACEUTICALS INC, Homology Medicines, Inc., Avalanche Biotechnologies, Inc., Cabaletta Bio, Inc., Frequency Therapeutics, Inc., FISCHER IMAGING CORP, and Schrodinger, Inc..
SEC CIK
DEERFIELD PARTNERS, L.P.'s CIK is 0001301041
Past Insider Trading and Trends
2006 was DEERFIELD PARTNERS, L.P.'s most active year for acquiring shares with 84 total transactions. DEERFIELD PARTNERS, L.P.'s most active month to acquire stocks was the month of November. 2015 was DEERFIELD PARTNERS, L.P.'s most active year for disposing of shares, totalling 148 transactions. DEERFIELD PARTNERS, L.P.'s most active month to dispose stocks was the month of May. 2021 saw DEERFIELD PARTNERS, L.P. paying a total of $333,020,601.60 for 41,576,324 shares, this is the most they've acquired in one year. In 2020 DEERFIELD PARTNERS, L.P. cashed out on 87,434,254 shares for a total of $18,052,380.80, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
DYNAVAX TECHNOLOGIES CORP (DVAX) Snapshot price: $12.92
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +24.35% | 950K |
$4.40 | $4,180,000.00 | 4.85M |
Oct 4
| |||
Form 4
| +1.86% | 69.2K |
$5.61 | $384,670.40 | 3.8M |
Apr 28 - May 1
| |||
Form 4/A
| +0.71% | 25.28K |
$6.02 | $152,068.00 | 3.59M |
Apr 5
| |||
Form 4
| +3.96% | 142.09K |
$5.50 | $781,795.92 | 3.73M |
Apr 20 - Apr 24
| |||
Form 4
| +3.53% | 122.48K |
$6.03 | $738,516.68 | 3.59M |
Apr 3 - Apr 5
| |||
Form 4
| +3.61% | 120.61K |
$5.97 | $720,008.39 | 3.47M |
Mar 15 - Mar 17
| |||
Form 4
| +0.99% | 32.8K |
$6.02 | $197,234.51 | 3.34M |
Mar 7 - Mar 9
| |||
Form 4
| +3.73% | 119.23K |
$5.90 | $703,600.07 | 3.31M |
Mar 3
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ARENA PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.49% | -25.00K |
$10.51 | -$262,684.99 | 5.1M |
Oct 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Auspex Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.45M |
—
|
—
|
0
|
May 5
| |||
Form 4
| +50.86% | 1.5M |
$56.50 | $84,750,000.00 | 4.45M |
Jan 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
REGENXBIO Inc. (RGNX) Snapshot price: $14.565
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.34M |
$22.00 | $1,925,000.00 | 1.34M |
Sep 22
| |||
No matching records found |
Oncology Institute, Inc. (TOI) Snapshot price: $2.18
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 85.15K |
—
|
—
| 85.15K |
Nov 12
| |||
Form 4
|
∞
| 5M |
$10.00 | $50,000,000.00 | 5M |
Mar 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |